CertifyOS launched a shared credentialing program that allows providers to submit their information once for multiple health plans. The post UHC, Cigna and Centene Sign On to New National Shared Credentialing Program appeared first on MedCity News.

Eli Lilly’s partnership with InnoCare Pharma follows deals struck this year with other China-based companies. While indications for the new alliance remain undisclosed, InnoCare specializes in oncology and autoimmune drugs. The post Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to Start R&D Pact appeared first on MedCity News.

Healthcare has a habit of embracing patient empowerment right up until patients become powerful. The post From OpenNotes to “Doc Can I Record You?” Why Physicians Should Embrace Era of Accountability appeared first on MedCity News.

The Centers for Medicare & Medicaid Services (CMS) took constructive steps in its 2027 final rule and rate announcement, particularly on payment integrity and quality measurement. But those steps are not the finish line. Policymakers should further modernize MA to strengthen competition, transparency and accountability. Here’s where to start. The post Modernizing Medicare Advantage for the Next Generation of Seniors appeared first on MedCity News.

Roche reported the drug sefaxersen achieved statistically significant and clinically meaningful results in a Phase 3 test in immunoglobulin A nephropathy, or IgAN. This antisense oligonucleotide, which came from Ionis Pharmaceuticals, could offer advantages over other drugs currently available for treating this rare chronic disease of the kidneys. The post Phase 3 Data Could Make Roche Drug a Contender to Treat Rare Kidney Disease` appeared first on MedCity News.

The Series A round was led by .406 Ventures, with support from Emerson Collective (managed by Yosemite), Forerunner, Serena Ventures and Japan-based MPower Partners. The post Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device appeared first on MedCity News.

At the annual South Asian Health Leaders Forum held in Boston last week, Shiv Rao talked candidly about his biography and how it propelled him to build Abridge The post Who is Abridge’s CEO Shiv Rao? No, Really… appeared first on MedCity News.

Years of joint industry-academic engineering suggest that highly engineered single agents will not be the most effective treatments for solid tumors; the solution will be combining the right drugs and administering them in the right way. The post Innovation in Oncology: The Synergy of New and Old Drugs appeared first on MedCity News.

Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, using AI-powered triage to connect patients with appropriate treatment. The post Pelago Unveils New Behavioral Health Platform for Substance Use, Mental Health and Behavioral Addiction Care appeared first on MedCity News.

The Oracle Health Clinical AI Agent is unique in the way it’s embedded directly in the Oracle Health Foundation EHR, making it easier for nurses who don’t have to shift between tools used for separate tasks. The post How is Oracle Health’s Nurse AI Agent Different? appeared first on MedCity News.

Amgen’s dazodalibep led to statistically significant and clinically meaningful results, according to preliminary Phase 3 results in Sjögren’s disease. This fusion protein could compete against a Novartis antibody under an FDA review that could make it the first Sjögren’s therapy. The post Amgen Drug Meets Goals of Key Test in Common Autoimmune Disease With No Approved Meds appeared first on MedCity News.

Healthcare leaders know how to test software. We don’t yet have a shared playbook for onboarding agents expected to do a job end to end. That is the gap a probation period is meant to fill. The post AI Workers Need a Probation Period, Not Just a Pilot appeared first on MedCity News.

Telix Pharmaceuticals is acquiring Isotope Technologies Munich, or ITM, in a $1.65 billion stock deal that will create a radiopharmaceuticals company with greater global scale. ITM’s lead pipeline asset is in late-stage development for a type of gastrointestinal cancer, where it could compete against Novartis and Curium Pharma products. The post Radiopharmaceutical Dealmaking Continues With Telix’s $1.65B ITM Acquisition appeared first on MedCity News.

Array Behavioral Care launched a new service to help providers assess patients with urgent behavioral health needs and connect them to appropriate care. The post Array Behavioral Care Unveils New Triage Model appeared first on MedCity News.

Since implementing AI clinical documentation improvement (CDI) tools, Intermountain has seen a 22% point increase in inpatient chart completion during or immediately after rounds. The post How AI Is Transforming Clinical Documentation at Intermountain Health appeared first on MedCity News.